DYADIC INTERNATIONAL INC Equity Securities FVNINoncurrent
DYADIC INTERNATIONAL INC (DYAI) had Equity Securities FVNINoncurrent of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Long-Term Investments
us-gaap:EquitySecuritiesFVNINoncurrent · last filed 2024-03-28
- 2023-12-31: Equity Securities FVNINoncurrent $0.00.
- 2023-09-30: Equity Securities FVNINoncurrent $0.00.
- 2023-06-30: Equity Securities FVNINoncurrent $0.00.
- 2022-12-31: Equity Securities FVNINoncurrent $284.71K.
| Period end | Equity Securities FVNINoncurrent |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2022-12-31 | $284.71K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |